A medical team in Thailand is planning to conduct clinical trials of stem-cell therapy to treat three major neural diseases for the first time in the country.

The project seeks to help victims of Parkinson’s disease, spinal cord injury and strokes, and trials of transplanting developed stem cells into patients’ central nervous systems are expected to begin this year, Maiyadhaj Samsenat, director of Thailand’s Prasat Neurological Institute revealed on Thursday at the annual academic conference of the Department of Medical Services, started from Tuesday in Bangkok.

According to Maiyadhaj, a team of about 12 neurological and stem-cell experts from the institute is currently reviewing the published results of related studies from all over the world for the project.

The budget requirement for the first year has been set at 10 million baht (263 thousand U.S. dollars).

Cell engineering and tissue growth laboratory at Mahidol University, renowned for advanced medical research in Thailand, will develop the proper type of stem cells for the project, said Ahnond Bunyaratvej, the secretary-general of the National Research Council of Thailand.

Link


  • Stem Cell Heart Study To Begin in Thailand
  • Congestive Heart Failure Patient Seeks Stem-Cell Therapy Overseas
  • Invention of cancer stem cell marker will stop cancer from returning
  • Stem Cell Therapy to Prevent Strokes Held Up by US Regulator
  • Legislature to review stem cell institutes in the state
  • Stupidity on the rise: UN approves human cloning ban
  • Indian Stem Cell Research Would be Guided by an Appropriate Strategy in Near Future
  • Sales of Stem Cell Products Expected to Surpass $35 Million in 2007
  • Schwarzenegger and McGuinty are Set for a New Stem Cell Research Joint Venture
  • Stem Cell Clinical Trial for Heart Attack Patients Reaches Safety Milestone